By
Drug Target Review2024-01-10T16:00:50
Novel self-assembled amino acid-based nanoparticles, loaded with doxorubicin, could evolve cancer treatment.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2025-11-13T14:00:00
Sponsored by Cell Signaling Technology
2024-01-26T13:22:42
Sponsored by bit.bio
2026-06-04T07:05:00
Author Graham Craig
2025-09-18T12:00:00
Sponsored by Benchling
2024-01-10T08:23:16
Sponsored by BellBrook Labs
2023-12-11T10:49:07
Sponsored by Leica Microsystems
Site powered by Webvision Cloud